The proposed clinical trial with TPST-1495 can help people with two types of cancer,
Endometrial Cancer (EC) and Colorectal Carcinoma (CRC), who need surgery. The investigator
plans to evaluate how well TPST-1495 works against these cancers by checking blood samples
and tumor tissues taken before and after the treatment to see if it is an effective treatment
option to help the immune system fight against cancer.